Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Predictor of Early Recovery on Urinary Continence After Laparoscopic Radical Prostatectomy
This clinical trial update examines predictors of early urinary continence recovery after laparoscopic radical prostatectomy for prostate ca…
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: Radium(223) Dichloride (Alpharadin) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases [Phase 3]
Phase 3 trial of Alpharadin (radium-223 dichloride) in men with castration-resistant prostate cancer and bone metastases has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: Character Traits and Stress in Suspected Prostate Cancer
A clinical trial evaluating character traits and stress in suspected prostate cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Study of Effectiveness of IMC-A12 Antibody Combined With Hormone Therapy Prior to Surgery to Treat Prostate Cancer [Phase 2]
Phase 2 study update evaluating IMC-A12 (cixutumumab) in combination with hormone therapy before surgery for prostate cancer.
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey "Long-term Use Survey in Prostate Cancer Patients (96 Weeks)"
This completed clinical trial assessed the long-term use of Leuplin SR 11.25 mg in prostate cancer patients, with 96-week follow-up results …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting Conditions [Phase 1]
Phase 1 relative bioavailability study comparing a generic bicalutamide 50 mg tablet with Casodex (bicalutamide) after a 50 mg dose in healt…
-
CLINICAL_TRIALS research · 2017-03-28Clinical Trial Update: Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fed Conditions [Phase 1]
Phase 1 relative bioavailability study comparing a Bicalutamide 50 mg tablet (Sandoz) with Casodex under fed conditions in healthy subjects.
-
CLINICAL_TRIALS approval · 2017-03-24Clinical Trial Update: Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Regulatory approval has been granted for abiraterone acetate (Zytiga) for advanced prostate cancer, indicating marketing authorization for t…
-
CLINICAL_TRIALS trial_result · 2017-03-24Clinical Trial Update: Abiraterone-Rechallenge Study for CRPC Patients [Phase 2]
A Phase 2 trial evaluating Abiraterone rechallenge in patients with castration-resistant prostate cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-03-23Clinical Trial Update: Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer [Phase 3]
Phase 3 trial completed evaluating nadroparin in patients with lung, pancreatic, or prostate cancer, focusing on venous thrombosis.
-
CLINICAL_TRIALS trial_result · 2017-03-23Clinical Trial Update: Bicalutamide and Raloxifene in Treating Patients With Metastatic or Hormone-Refractory Prostate Cancer [EARLY_Phase 1]
Early-phase 1 trial evaluating the combination of bicalutamide and raloxifene in metastatic or hormone-refractory prostate cancer has comple…
-
CLINICAL_TRIALS withdrawal · 2017-03-22Clinical Trial Update: A Phase 2 Study of Bicalutamide Plus Finasteride in Men With MRI Detectable Prostate Nodules Undergoing Active Surveillance [Phase 2]
Phase 2 trial evaluating bicalutamide plus finasteride for MRI-detectable prostate nodules in men on active surveillance has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: PET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate Cancer [Phase 1, Phase 2]
A Phase 1/2 PET/CT imaging study of [68Ga]RM2 in primary prostate cancer was terminated, with status indicating the trial has ended.
-
CLINICAL_TRIALS trial_result · 2017-03-21Clinical Trial Update: MRI in Active Surveillance of Prostate Cancer [NA]
The clinical trial evaluating MRI in active surveillance of prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-21Clinical Trial Update: Olive Oil v Prostate Cancer Foundation Diet for Treatment of Prostate Cancer [NA]
A completed clinical trial comparing an olive oil–based diet to a Prostate Cancer Foundation diet for the treatment of prostate cancer.
-
CLINICAL_TRIALS research · 2017-03-16Clinical Trial Update: Targeted Prostate Biopsy Using a Novel MRI-Ultrasound Fusion Device [NA]
An update on a clinical trial evaluating a novel MRI–ultrasound fusion device for targeted prostate biopsy in prostate cancer.
-
CLINICAL_TRIALS trial_result · 2017-03-15Clinical Trial Update: Antibiotic Prophylaxis for Urinary Catheter Removal After Radical Prostatectomy [NA]
Clinical trial evaluating antibiotic prophylaxis for urinary catheter removal after radical prostatectomy; the study was terminated and resu…
-
CLINICAL_TRIALS trial_result · 2017-03-15Clinical Trial Update: Phase I Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate Cancer [Phase 1]
A Phase I trial combining sodium selenite with docetaxel in castration-resistant prostate cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: 68Ga-PSMA PET/CT or PET/MRI in Evaluating Patients With Recurrent Prostate Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating 68Ga-PSMA PET/CT or PET/MRI in patients with recurrent prostate cancer has completed, with results pos…
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: Performance Evaluation of the AMS CONTINUUM™ Device [NA]
A completed clinical trial investigating the AMS CONTINUUM device for prostate cancer with posted results in 2017.
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone
A completed clinical trial evaluating bone imaging in metastatic prostate cancer using Carbon-11 acetate and Fluorodeoxyglucose F-18 PET sca…
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: Feasibility Study of Ultrasound Elastography Detecting Prostate Cancer [NA]
A completed feasibility study evaluated ultrasound elastography for detecting prostate cancer.
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Two-Dose Level Evaluation of NX-1207 for the Treatment of Low Risk, Localized (T1c) Prostate Cancer [Phase 2]
Phase 2 study evaluating two dose levels of NX-1207 for low-risk, localized prostate cancer (T1c); the study is completed.
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: A Study in Patients With Metastatic Prostate Cancer to Assess How the Drug Eligard®, Affects Certain Markers in Blood and Urine, Which Are Indicators for the Disease [Phase 4]
The Phase 4 trial evaluating Eligard (leuprolide acetate) in metastatic prostate cancer, focusing on disease biomarkers in blood and urine, …
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-induced Bone Loss (CTIBL) in Patients With Prostate Cancer on Hormone Therapy [Phase 3]
Phase 3 trial evaluating zoledronic acid and markers of bone resorption to predict bone metastases and cancer treatment-induced bone loss in…